Answers are grounded in this paper and cite their sources.
Periodontal diseases pose significant challenges to oral health, often requiring advanced therapeutic interventions involving the utilization of three-dimensional (3D) scaffolds, However, this intervention could not prevent inflammatory reactions. Hence, recent years have seen a growing emphasis on developing new antibacterial scaffolds in dental tissue engineering. This study aimed to address these challenges by evaluating the antibacterial and biocompatibility properties of a novel collagen-chitosan scaffold loaded with metronidazole nanoparticles (CC-MT) for periodontal therapy. The antibacterial activity of CC-MT against Porphyromonas gingivalis and Fusobacterium nucleatum was assessed using the disk diffusion test. Additionally, cytocompatibility was evaluated by examining cell viability and proliferation using Human Gingival Fibroblast cells (HGF-1), and cell attachment was characterized using filed emission scanning electron microscopy. Our findings revealed that CC-MT exhibited antibacterial effects against the pathogens, with CC-MT (30% metronidazole) showing a higher inhibitory effect, with no significant difference compared to the positive control (metronidazole disc) (p < 0.05). In addition, in vitro cell culture studies revealed that the CC-MT (30% metronidazole) has no negative effect on cell morphology, viability, and proliferation and possesses good biocompatibility. Based on these results, CC-MT demonstrated potential as drug carriers and could be promising candidates for the treatment of periodontal disease.
No takes yet. Share an insight, caveat, or question.
Zayi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: